HPV — India

Cervical cancer is a leading cause of cancer death in women, and a domestically produced vaccine has changed what is possible.

Illustration: HPV — India

The legal framework

India carries one of the world's largest burdens of cervical cancer. Vaccination has not historically been part of the universal immunisation programme, though several states introduced it and a domestically manufactured vaccine, launched in 2023, brought the price down dramatically. Screening in the national programme relies mainly on visual inspection with acetic acid, delivered through health workers.

Cervical cancer is one of the leading causes of cancer death among Indian women, and HPV vaccination was for years available only privately at significant cost. A domestically produced vaccine has changed the economics, and introduction into the national immunisation programme has been announced and prepared in stages. Screening in most of the country uses visual inspection with acetic acid rather than laboratory tests.

Key points

BurdenAmong the highest numbers of cervical cancer cases and deaths in the world
VaccineA domestically produced vaccine launched in 2023 at a far lower price
ProgrammeIntroduction into the universal immunisation programme has been under consideration; some states act independently
ScreeningVisual inspection with acetic acid in the national programme
Age groupWomen aged 30 to 49 targeted for screening
Health workersASHA workers mobilise women for screening at village level
CostScreening is free at public facilities

In practice

Cost and coverage

Screening is free at public facilities; vaccine prices have fallen sharply since domestic production began.

Where to go

Worth knowing

Visual inspection gives a result during the visit, which means a lesion can often be treated the same day. That single fact is why the method is used at scale where laboratories are scarce.

Frequently asked questions

Is the HPV vaccine available in India?

Yes, including a domestically produced vaccine that costs far less than imported ones, and introduction into the national immunisation programme has been prepared in stages with some states moving first. Outside the public programme it is available privately at a chemist or clinic on prescription.

Why vaccinate boys as well as girls?

Because HPV causes cancers of the penis, anus and throat as well as the cervix, and genital warts in both sexes — and because high coverage in both sexes cuts transmission for everyone far faster than vaccinating girls alone. Programmes that include boys reach population-level protection years earlier, which is why almost every country that started with girls has since extended it.

Official sources and links

← All countries HPV →

Page checked in September 2026. The instruments cited can change: if in doubt, confirm with the official source given.

Locate this page in the site map

A question, a correction, a suggestion? Write to us.